Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Development Of Biopharmaceutical Ophthalmic Product

Sept 30 (Reuters) - Essex Bio-Technology Ltd  1061.HK :
    * GROUP IN DISCUSSION ON POTENTIAL CO-DEVELOPMENT OF
BIOPHARMACEUTICAL OPHTHALMIC PRODUCT
    * DISCUSSION WITH INDEPENDENT THIRD PARTY ALSO REGARDING
LICENSING
OF RELEVANT INTELLECTUAL PROPERTY RIGHTS

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS5nNXTh
Further company coverage:  1061.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news